The emergence of the SARS-CoV-2 Omicron variant

Hämta fulltext
Series

How is Omicron different?

Hämta fulltext
Series

SARS-CoV-2 variants implications for immunity and vaccine development /

Hämta fulltext
Series

SARS-CoV-2 evolution emergence of the "Californian" and "Indian" variants /

Hämta fulltext
Series

SARS-CoV-2 evolution within and between individuals

Hämta fulltext
Series

Identifying SARS-CoV-2 proteases

Hämta fulltext
Series

Genetic surveillance and the emergence of SARS-CoV-2 variants

Hämta fulltext
Series

The role of short linear motifs (SLiMs) in SARS-CoV-2 entry into human cells

Hämta fulltext
Series

The role of Neuropilin-1 as a SARS-CoV-2-specific endocytosis potentiator

Hämta fulltext
Series

COVID-19 epidemiology and variants new challenges and future of the pandemic /

Hämta fulltext
Series

Interspecies transmission of SARS-CoV-2

Hämta fulltext
Series

SARS-CoV-2 mutations phenotypes and implications for vaccine development /

Hämta fulltext
Series

The evolutionary origin of SARS-CoV-2

Hämta fulltext
Series

An FDA approved salivary test for SARS-CoV-2 infection

Hämta fulltext
Series

A novel AIOD-CRISPR system for diagnosis of SARS-COV-2

Hämta fulltext
Series

SARS-COV-2 what we need to know and possible future therapies /

Hämta fulltext
Series

The COVID-19 coronavirus outbreak March 2020 update /

Hämta fulltext
Series

SARS-COV-2 vaccine current biological targets and considerations /

Hämta fulltext
Series

The current understanding of the biology of the SARS-COV-2 virus

Hämta fulltext
Series

The paediatric response to the SARS-COV-2 virus and what we can learn from it

Hämta fulltext
Series